Johnson & Johnson has proposed a settlement of up to $5.5 billion to resolve numerous lawsuits claiming that its talc-based baby powder causes ovarian cancer. This move aims to conclude a lengthy legal dispute that has burdened the company for years, despite its consistent denial of the allegations.
The company has altered its baby powder formula and ceased sales in the U.S. over two years ago, transitioning to a cornstarch-based product. J&J maintains that studies support the safety of its talc products, which have faced scrutiny due to potential asbestos contamination.
Watch for how the proposed settlement impacts J&J's reputation and future product strategies. The shift to cornstarch-based products may influence consumer trust and market dynamics. Keep an eye on ongoing litigation trends and regulatory responses regarding talc safety.